Literature DB >> 17674041

Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.

Inti Zlobec1, Luigi Terracciano, Jeremy R Jass, Alessandro Lugli.   

Abstract

The purpose of this study was to determine whether staining intensity in conjunction with the percentage of positive tumor cells should be used as an indicator of protein expression detected by immunohistochemistry. A tissue microarray of 1,197 colorectal cancers was immunostained for p53, Her2/neu, epidermal growth factor receptor (EGFR), adenomatosis polyposis coli (APC), and beta-catenin. Immunoreactivity was described by the percentage of positive tumor cells (percent positivity) and by the staining intensity (weak, moderate, strong). The interobserver reproducibility of both was evaluated by two pathologists. The association of T stage, N stage, tumor grade, vascular invasion, and survival with percent positivity, staining intensity, and the combination of both was assessed. In univariate analysis, protein expression assessed by percent positivity resulted in 11 significant associations between the proteins and clinico-pathological features. Eight of these 11 were also demonstrated using only the degree of staining intensity. However, more than half of the associations identified by percent positivity alone were lost when staining intensity was also analyzed in combination with the percentage of positive tumor cells. A scoring method based on percent positivity, rather than on staining intensity, for p53, Her2/neu, EGFR, APC, and beta-catenin is reproducible and appears to be sufficient for establishing associations of the selected tumor markers with most clinico-pathological features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674041     DOI: 10.1007/s00428-007-0466-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.

Authors:  Alessandro Lugli; Inti Zlobec; Ursula Günthert; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Journal:  Mod Pathol       Date:  2006-06-09       Impact factor: 7.842

2.  Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.

Authors:  Inti Zlobec; Parham Minoo; Kristi Baker; David Haegert; Karim Khetani; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Journal:  Eur J Cancer       Date:  2007-03-12       Impact factor: 9.162

3.  Impact of EGFR expression on colorectal cancer patient prognosis and survival.

Authors:  J-P Spano; C Lagorce; D Atlan; G Milano; J Domont; R Benamouzig; A Attar; J Benichou; A Martin; J-F Morere; M Raphael; F Penault-Llorca; J-L Breau; R Fagard; D Khayat; P Wind
Journal:  Ann Oncol       Date:  2005-01       Impact factor: 32.976

4.  Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

Authors:  Heather Hampel; Julie A Stephens; Eero Pukkala; Risto Sankila; Lauri A Aaltonen; Jukka-Pekka Mecklin; Albert de la Chapelle
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

5.  Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.

Authors:  Inti Zlobec; Russell Steele; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Journal:  J Clin Pathol       Date:  2006-12-20       Impact factor: 3.411

6.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Authors:  H Moch; P Schraml; L Bubendorf; M Mirlacher; J Kononen; T Gasser; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.

Authors:  M Bärlund; F Forozan; J Kononen; L Bubendorf; Y Chen; M L Bittner; J Torhorst; P Haas; C Bucher; G Sauter; O P Kallioniemi; A Kallioniemi
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

8.  A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods.

Authors:  Inti Zlobec; Russell Steele; Nilima Nigam; Carolyn C Compton
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

9.  Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.

Authors:  Megan M Garrity; Lawrence J Burgart; Michelle R Mahoney; Harold E Windschitl; Muhammad Salim; Martin Wiesenfeld; James E Krook; John C Michalak; Richard M Goldberg; Michael J O'Connell; Alfred F Furth; Daniel J Sargent; Linda M Murphy; Eunice Hill; Darren L Riehle; Cecelia H Meyers; Thomas E Witzig
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

10.  Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Authors:  David Azria; Frederic Bibeau; Nicolas Barbier; Abderrahim Zouhair; Claire Lemanski; Philippe Rouanet; Marc Ychou; Pierre Senesse; Mahmut Ozsahin; André Pèlegrin; Jean-Bernard Dubois; Simon Thèzenas
Journal:  BMC Cancer       Date:  2005-06-20       Impact factor: 4.430

View more
  19 in total

1.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma.

Authors:  Hassan Ashktorab; Kevin Belgrave; Fatemeh Hosseinkhah; Hassan Brim; Mehdi Nouraie; Mikiko Takkikto; Steve Hewitt; Edward L Lee; R H Dashwood; Duane Smoot
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

3.  Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.

Authors:  Hyung-Seok Kim; Seon-Young Yoo; Kyung-Tae Kim; Jong-Tae Park; Hyun-Jong Kim; Jung-Chul Kim
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

4.  Low expression of secreted frizzled-related protein 2 and nuclear accumulation of β-catenin in aggressive nonfunctioning pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Linchuan Hong; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

5.  Evaluation of Accessory Lacrimal Gland in Muller's Muscle Conjunctival Resection Specimens for Precursor Cell Markers and Biological Markers of Dry Eye Disease.

Authors:  Marwan Ali; Dhara Shah; Zeeshan Pasha; Sarmad H Jassim; Assraa Jassim Jaboori; Pete Setabutr; Vinay K Aakalu
Journal:  Curr Eye Res       Date:  2016-09-09       Impact factor: 2.424

6.  ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.

Authors:  Glauco Baiocchi; Ademar Lopes; Renata A Coudry; Benedito M Rossi; Fernando A Soares; Samuel Aguiar; Gustavo C Guimarães; Fabio O Ferreira; Wilson T Nakagawa
Journal:  Int J Colorectal Dis       Date:  2009-04-24       Impact factor: 2.571

7.  Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.

Authors:  Youtu Wu; Jiwei Bai; Zhenye Li; Fei Wang; Lei Cao; Chunhui Liu; Shengyuan Yu; Guoqiang Yu; Yazhuo Zhang
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

8.  Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.

Authors:  Mosmi Surati; Matthew Robinson; Suvobroto Nandi; Leonardo Faoro; Carley Demchuk; Cleo E Rolle; Rajani Kanteti; Benjamin D Ferguson; Rifat Hasina; Tara C Gangadhar; April K Salama; Qudsia Arif; Colin Kirchner; Eneida Mendonca; Nicholas Campbell; Suwicha Limvorasak; Victoria Villaflor; Thomas A Hensing; Thomas Krausz; Everett E Vokes; Aliya N Husain; Mark K Ferguson; Theodore G Karrison; Ravi Salgia
Journal:  J Clin Bioinforma       Date:  2011-02-28

9.  Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series.

Authors:  Jarle Bruun; Matthias Kolberg; Jahn M Nesland; Aud Svindland; Arild Nesbakken; Ragnhild A Lothe
Journal:  Front Oncol       Date:  2014-05-21       Impact factor: 6.244

10.  Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.

Authors:  I Zlobec; T Vuong; C C Compton; A Lugli; R P Michel; S Hayashi; J R Jass
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.